Studi Pengikatan Cadmium (II) pada Resin Anorganik Titanium Oksida dan Zirkonium Oksida
Kata Kunci:
Cd-(II)-binding capacity, inorganic oxide resins, titanium oxide, zirconium oxideAbstrak
Immobilization of Cd-(II) in production technology of indium medical radioisotopes (lll In or 115min) by means of 112Cd (p, 2n) 11 In or 114Cd (n,y) 115Cd 115mIn nuclear reaction is an important step regarding to the quality of the produced radioactive indium and efficiency of the utilization of the enriched targets (112Cd or 114Cd). The phenomena and capacity of Cd-(II) immobilization were studied using two kinds of inorganic oxide resins, i.e. titanium oxide and zirconium oxide. The aim of this study is gaining experimental data supporting the utilization of the resins in the production of 111In and 115min. The immobilization of Cd-(II) was proceeded by treating standard solutions of Cd-(II) with the resins followed by measurement of Cd-(II) content of the treated solution before and after treatment. The separation of the treated Cd-(II) solution from the resin was performed by means of centrifugation, while the measurement of Cd-(II) was performed by means of Ultra Violet spectrophotometry. The ready-used titanium oxide from Merck did not bind Cd-(II) even after being treated with several kinds of activating media. Zirconium oxide synthesized from the reaction of ZrOCI,. 8H,O with a basic solution of NaOH was in the form of the hydrate compound formulated as ZrO. nH,O with the value of n=(1.7034 +0.0186) and showed a capability to bind Cd-(II) higher than that of zirconium oxide synthesized with a basic solution of NH,OH or of the ready-used ZrO2. In general the Cd-(II)-binding capacity of Zro, tends to decrease with increasing of the amount of Zro.
Referensi
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

















